vs
LEE ENTERPRISES, Inc（LEE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是LEE ENTERPRISES, Inc的1.6倍（$207.3M vs $130.1M），LEE ENTERPRISES, Inc净利率更高（-4.3% vs -62.0%，领先57.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -10.0%），LEE ENTERPRISES, Inc自由现金流更多（$3.7M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -5.8%）
李企业是一家上市美国传媒企业，在全美25个州运营着72份日报，同时还经营超过350份周报、分类广告刊物及各类专业刊物。公司由阿尔弗雷德·威尔逊·李于1890年创立，总部坐落于爱荷华州达文波特。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
LEE vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $130.1M | $207.3M |
| 净利润 | $-5.6M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 4.0% | -54.7% |
| 净利率 | -4.3% | -62.0% |
| 营收同比 | -10.0% | 25.9% |
| 净利润同比 | 66.5% | 3.5% |
| 每股收益（稀释后） | $-0.92 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $130.1M | $207.3M | ||
| Q3 25 | $139.1M | $159.9M | ||
| Q2 25 | $141.3M | $166.5M | ||
| Q1 25 | $137.4M | $139.3M | ||
| Q4 24 | $144.6M | $164.6M | ||
| Q3 24 | $158.6M | $139.5M | ||
| Q2 24 | $150.6M | $147.0M | ||
| Q1 24 | $146.6M | $108.8M |
| Q4 25 | $-5.6M | $-128.6M | ||
| Q3 25 | $-6.4M | $-180.4M | ||
| Q2 25 | $-1.9M | $-115.0M | ||
| Q1 25 | $-12.5M | $-151.1M | ||
| Q4 24 | $-16.7M | $-133.2M | ||
| Q3 24 | $-10.1M | $-133.5M | ||
| Q2 24 | $-4.3M | $-131.6M | ||
| Q1 24 | $-12.2M | $-170.7M |
| Q4 25 | 4.0% | -54.7% | ||
| Q3 25 | -1.0% | -106.9% | ||
| Q2 25 | 3.3% | -64.8% | ||
| Q1 25 | -3.3% | -102.6% | ||
| Q4 24 | -2.3% | -74.3% | ||
| Q3 24 | -2.3% | -94.6% | ||
| Q2 24 | 3.3% | -79.1% | ||
| Q1 24 | -3.1% | -151.9% |
| Q4 25 | -4.3% | -62.0% | ||
| Q3 25 | -4.6% | -112.8% | ||
| Q2 25 | -1.4% | -69.0% | ||
| Q1 25 | -9.1% | -108.5% | ||
| Q4 24 | -11.6% | -80.9% | ||
| Q3 24 | -6.4% | -95.7% | ||
| Q2 24 | -2.8% | -89.5% | ||
| Q1 24 | -8.3% | -156.8% |
| Q4 25 | $-0.92 | $-1.28 | ||
| Q3 25 | $-1.02 | $-1.81 | ||
| Q2 25 | $-0.31 | $-1.17 | ||
| Q1 25 | $-2.07 | $-1.57 | ||
| Q4 24 | $-2.80 | $-1.34 | ||
| Q3 24 | $-1.68 | $-1.40 | ||
| Q2 24 | $-0.73 | $-1.52 | ||
| Q1 24 | $-2.06 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.6M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-48.7M | $-80.0M |
| 总资产 | $592.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $12.6M | $421.0M | ||
| Q3 25 | $10.0M | $202.5M | ||
| Q2 25 | $14.1M | $176.3M | ||
| Q1 25 | $4.7M | $127.1M | ||
| Q4 24 | $6.1M | $174.0M | ||
| Q3 24 | $9.6M | $150.6M | ||
| Q2 24 | $13.4M | $480.7M | ||
| Q1 24 | $16.1M | $112.3M |
| Q4 25 | $-48.7M | $-80.0M | ||
| Q3 25 | $-43.3M | $9.2M | ||
| Q2 25 | $-40.5M | $151.3M | ||
| Q1 25 | $-38.9M | $144.2M | ||
| Q4 24 | $-26.7M | $255.0M | ||
| Q3 24 | $-9.9M | $346.8M | ||
| Q2 24 | $4.0M | $432.4M | ||
| Q1 24 | $7.9M | $140.3M |
| Q4 25 | $592.6M | $1.5B | ||
| Q3 25 | $601.7M | $1.2B | ||
| Q2 25 | $622.7M | $1.3B | ||
| Q1 25 | $623.9M | $1.3B | ||
| Q4 24 | $633.0M | $1.5B | ||
| Q3 24 | $649.2M | $1.5B | ||
| Q2 24 | $677.5M | $1.6B | ||
| Q1 24 | $684.8M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.5M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $3.7M | $-100.8M |
| 自由现金流率自由现金流/营收 | 2.9% | -48.6% |
| 资本支出强度资本支出/营收 | 0.6% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.5M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $4.5M | $-99.8M | ||
| Q3 25 | $-6.3M | $-91.4M | ||
| Q2 25 | $8.9M | $-108.3M | ||
| Q1 25 | $-790.0K | $-166.5M | ||
| Q4 24 | $-7.3M | $-79.3M | ||
| Q3 24 | $-261.0K | $-67.0M | ||
| Q2 24 | $-1.9M | $-77.0M | ||
| Q1 24 | $3.2M | $-190.7M |
| Q4 25 | $3.7M | $-100.8M | ||
| Q3 25 | $-8.3M | $-92.7M | ||
| Q2 25 | $8.3M | $-110.7M | ||
| Q1 25 | $-2.2M | $-167.8M | ||
| Q4 24 | $-8.9M | $-79.5M | ||
| Q3 24 | $-2.9M | $-68.6M | ||
| Q2 24 | $-5.5M | $-79.0M | ||
| Q1 24 | $1.3M | $-193.9M |
| Q4 25 | 2.9% | -48.6% | ||
| Q3 25 | -6.0% | -58.0% | ||
| Q2 25 | 5.9% | -66.5% | ||
| Q1 25 | -1.6% | -120.5% | ||
| Q4 24 | -6.1% | -48.3% | ||
| Q3 24 | -1.8% | -49.2% | ||
| Q2 24 | -3.6% | -53.7% | ||
| Q1 24 | 0.9% | -178.2% |
| Q4 25 | 0.6% | 0.5% | ||
| Q3 25 | 1.4% | 0.8% | ||
| Q2 25 | 0.4% | 1.5% | ||
| Q1 25 | 1.0% | 1.0% | ||
| Q4 24 | 1.1% | 0.1% | ||
| Q3 24 | 1.7% | 1.2% | ||
| Q2 24 | 2.4% | 1.4% | ||
| Q1 24 | 1.3% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LEE
| Advertising And Marketing Services | $60.0M | 46% |
| Subscription And Circulation | $57.7M | 44% |
| Other | $12.4M | 10% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
